3,4,6-TRi-o-acetyl-2-deoxy-2-phthalimido-b-d-glucopyranosyl fluoride

Catalog No. :
ACZEAV098
CAS No. :
130539-42-3
Molecular Formula :
C20H20FNO9
Molecular Weight :
437.38

IUPAC Name:(2R,3S,4R,5R,6S)-2-(acetoxymethyl)-5-(1,3-dioxoisoindolin-2-yl)-6-fluorotetrahydro-2H-pyran-3,4-diyl diacetate

3,4,6-TRi-o-acetyl-2-deoxy-2-phthalimido-b-d-glucopyranosyl fluoride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$216.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,4,6-TRi-o-acetyl-2-deoxy-2-phthalimido-b-d-glucopyranosyl fluoride
IUPAC Name(2R,3S,4R,5R,6S)-2-(acetoxymethyl)-5-(1,3-dioxoisoindolin-2-yl)-6-fluorotetrahydro-2H-pyran-3,4-diyl diacetate
MDL No.MFCD01862268
Molecular FormulaC20H20FNO9
Molecular Weight437.38
SMILESCC(OC[C@H]1O[C@H]([C@H](N2C(C3=C(C2=O)C=CC=C3)=O)[C@H]([C@@H]1OC(C)=O)OC(C)=O)F)=O
InChI KeyYRVBOYANNCZRHU-DUQPFJRNSA-N
Synonymβ-D-Glucopyranosyl fluoride, 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-, 3,4,6-triacetate
CAS No.130539-42-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACZEAV098 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACZEAV098 route product structure diagram
    ACZEAV098130539-42-3
Inquiry

2. ACZEAV098 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACZEAV098 route product structure diagram
    ACZEAV098130539-42-3
Inquiry

Comments (0)